Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

January 1, 2022

Conditions
Hair Transplantation
Interventions
OTHER

autologous hair follicle derived mesenchymal stem cell suspension

Healthy hair follicles were extracted from the occipital area and treated to obtain hair follicle mesenchymal stem cells suspensions. The recipient sites were divided into two groups. Nine points were injected in a 1 cm2 area, and 100 μl of solution containing either 1 × 105 cells or normal saline was injected at each point. The follow-up duration was 9 months.

Trial Locations (1)

510000

Department of Plastic and Aesthetic Surgery, Nanfang Hospital Southern 8 Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER

NCT05659095 - Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA | Biotech Hunter | Biotech Hunter